Actively Recruiting
Efficacy of Lavender Essential Oil Chest Wraps in Improving Cough and Respiratory Distress in Infants With Bronchiolitis: a Multicenter Randomized Controlled Trial
Led by University Hospital, Geneva · Updated on 2025-03-30
400
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating if lavender essential oil chest wraps can help relieve cough and improve breathing difficulties, nighttime awakenings, and parental impact in infants with bronchiolitis compared to standard care. This multicenter randomized controlled trial takes place at Geneva University Hospital and Fribourg Cantonal Hospital in Switzerland, involving infants hospitalized with bronchiolitis. The study is in phase 4 and aims to understand the effects of adding lavender oil chest wraps to usual treatment. Participants will be randomly assigned to one of two groups: one group will receive standard care plus lavender essential oil chest wraps, while the other will receive standard care alone. For those in the lavender group, a cotton cloth soaked with 10-15 ml of 10% lavender essential oil is heated and wrapped around the infant's chest, covered with a woolen fabric. Standard care follows national guidelines without additional wraps. During the study, researchers will monitor cough frequency up to two days and assess secondary outcomes such as crying episodes, respiratory rate at baseline and specific hours, oxygen supplementation needs and duration, hospital stay length, and parental satisfaction. The impact on parents will be measured using a specific questionnaire at discharge. The trial will closely observe infants throughout hospitalization and assess outcomes immediately at discharge, with participation lasting the hospital stay plus up to two days of follow-up.
CONDITIONS
Brief Title
Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of bronchiolitis based on respiratory distress and lung sounds
- Hospitalization for bronchiolitis
- Written informed consent provided
You will not qualify if you...
- Underlying diseases affecting heart or lung function such as congenital heart disease or severe chronic lung disease
- More than three previous episodes of bronchiolitis
- Critically ill infants needing immediate intensive care unit admission
- Respiratory deterioration requiring CPAP or ICU transfer during enrollment
- Atopic dermatitis, eczema, or skin lesions especially on the chest
- Oncologic disease
- Premature infants with mild bronchopulmonary dysplasia are allowed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 days
Participants receive lavender essential oil chest wraps or standard care while hospitalized for bronchiolitis.
Hospital stay with treatment and assessments during this period
Trial Site Locations
Total: 2 locations
1
Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland
Fribourg, Switzerland, 1708
Actively Recruiting
2
Children's' Hospital, University Hospital of Geneva, Switzerland
Geneva, Switzerland, 1211
Actively Recruiting
Research Team
F
Fabiola Stollar, MD, PhD
T
Tido von Schoen-Angerer, MD, MPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here